CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $1.9M invested in Can-Fite BioPharma in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$198K
2
+$30.4K
3
+$23K
4
MC
Menta Capital
California
+$18.8K
5
UBS Group
UBS Group
Switzerland
+$16K

Top Sellers

1
-$30K
2
-$3K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.61M
2
$116K
3
$70K
4
$41K
5
$23K
6
$16K
7
$14K
8
$7K
9
$5K
10
–
11
–
12
–